// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Improving our patients’ understanding of their asthma

Emily Heiden - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Team Based Learning is a helpful strategy for teaching respiratory guidelines to Trainee Medical Doctors

Daniella Draicchio - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Pulmonary hypertension – an unmet need in undergraduate medical education

Natalie Hill - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Audience response systems may help build confidence and competence in diagnosing and managing asthma

William Ricketts - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Medical registrar experience of chest drains - a stab in the dark?

Francesca Conway - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - Investigation of the epithelial-mesenchymal paracrine interactions in lung tissue repair and fibrosis

Franco Conforti - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux

Jeanne-Marie Perotin-Collard - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

IL33 receptor activation is IL33 isoform and receptor genotype specific

Michael Portelli - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Alkaline phosphatase

Sputum gene signature comparison study between U-BIOPRED and Australia asthma cohorts

Stephany S�nchez-Ovando - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Using transcriptomics to understand the potential functions of lung function associated gene, GPR126 in human airway smooth muscle cells

Robert Hall - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Immunodeficiency, common variable, 10

N/A

Alpha 1 Antitrypsin Deficiency molecular mechanisms in liver organoids

Gema Gomez Mariano - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Alpha-1 antitrypsin (A1AT) deficiency

Alpha 1-Antitrypsin

Diesel particle induces aging phenotype of bronchial epithelial cells via disruption of anti-aging molecule

Jonathan R. Baker - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Type 2 cytokines and biomarkers in asthma patient sera show coordinated expression and identify patient subsets

Karina Bingham - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Differential macrophage activation in asthmatic sputum using U-BIOPRED transcriptomics

Angelica Tiotiu - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Spondylocostal dysostosis 5

N/A

Late Breaking Abstract - Generating iPSC derived alveolar macrophages as a novel model for respiratory research

Jessica Tilman - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Chronic obstructive pulmonary disease

N/A

The transition from normal lung anatomy to Fibrosis in IPF

feng xu - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Endotyping of COPD, bronchiectasis and their overlap syndrome by integrated sputum proteome/microbiome

Jeffrey T.-J. Huang - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Autoimmune sclerosing cholangitis

N/A

Subtypes of eosinophilic asthma with discrete gene pathway phenotypes

Jeanne-Marie Perotin-Collard - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Is Fezakinumab, an anti-IL22 antibody, a putative novel therapy for a subset of severe asthma?

Yusef Badi - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Fezakinumab

Epidemiology of lung function in a global severe asthma population

Michael Wechsler - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Copyright © 2026. QuantiNova All rights reserved